Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-21-034420
Filing Date
2021-10-12
Accepted
2021-10-12 19:47:26
Documents
1
Period of Report
2021-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3735
  Complete submission text file 0001140361-21-034420.txt   5072
Mailing Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199 (617) 351-2575
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Herbst Ronald (Reporting) CIK: 0001886107 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40881 | Film No.: 211319815